>R&D >R&D Pipeline

R&D Pipeline

Takeda discloses ethical drugs under development that have entered phase 1 clinical trials or above in Japan, the U.S. or Europe. The pipeline is updated each quarter.

PDF PDF 0.1MB 4P

About the R&D Pipeline

Clinical trials are conducted on humans for drugs for which basic research and non-clinical trials have been completed. Drugs that have undergone efficacy and safety evaluation via three phases of clinical trials are launched onto the market after approval by the regulatory authorities.